Aiforia
Develops AI-powered cancer diagnostic tools to help healthcare organizations improve the analysis and delivery of oncology diagnostics.
Overview
Aiforia builds AI-powered cancer diagnostics aimed at healthcare organizations involved in oncology testing and clinical decision support. Its offering applies artificial intelligence to the diagnostic workflow, positioning the company in the market for more scalable and technology-enabled cancer detection. The Helsinki-based company secured €20 million in European Investment Bank venture debt financing in August 2026. The funding is intended to advance its AI-powered cancer diagnostics, providing non-dilutive capital to support product development and commercialization.
Funding History
Helsinki-based Aiforia secures €20 million EIB financing to advance AI-powered cancer diagnostics
Frequently Asked Questions
- How much has Aiforia raised in total?
- Aiforia has raised a total of $20M across 1 funding round.
- What does Aiforia do?
- Aiforia builds AI-powered cancer diagnostics aimed at healthcare organizations involved in oncology testing and clinical decision support. Its offering applies artificial intelligence to the diagnostic workflow, positioning the company in the market for more scalable and technology-enabled cancer detection. The Helsinki-based company secured €20 million in European Investment Bank venture debt financing in August 2026. The funding is intended to advance its AI-powered cancer diagnostics, providing non-dilutive capital to support product development and commercialization.
- Where is Aiforia headquartered?
- Aiforia is headquartered in Helsinki, Finland.
Related Insights
A comprehensive analysis of Sage's funding history, investors, competitive position, and growth trajectory in the AI Healthcare space.
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $25.9 billion raised across 94 deals, with 14 mega-rounds capturing 79.8% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.